News
FDA Warns of Heart Risk With Pfizer, Moderna COVID Vaccines
The updated warnings highlight a rare risk of heart inflammation in teen boys and young men, CBS News reported. The warning applies to males ages 16 to 25 and is based on new data from FDA safety monitoring and a 2023 study. This includes both Pfizer's Comirnaty and Moderna's Spikevax vaccines.
Moderna on Thursday pushed back the time frame for likely approval of a combination vaccine meant to protect against both ...
The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...
Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were instrumental in saving lives during the COVID pandemic.
Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...
Moderna isn’t giving up on the combo shot entirely—it plans to resubmit later this year after it collects more data from its ...
Moderna has withdrawn the Biologics License Application (BLA) for mRNA-1083, a combination vaccine against seasonal influenza and SARS-CoV-2, after ...
In terms of liquidity and interest, the mean open interest for Moderna options trades today is 1389.55 with a total volume of ...
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback